These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 19744739

  • 21. Thyrotoxic periodic paralysis induced by pegylated interferon alpha plus ribavirin for chronic hepatitis C.
    Yang WS, Chu PL, Liu CH, Chung GB, Wu KD.
    J Clin Gastroenterol; 2008 Jan; 42(1):112-3. PubMed ID: 18097301
    [No Abstract] [Full Text] [Related]

  • 22. Catatonia associated with pegylated interferon-α 2b and ribavirin for hepatitis C.
    Quinn D, Kuchler E, Deming P, Arora S.
    Psychosomatics; 2012 Jan; 53(4):400-1. PubMed ID: 22748752
    [No Abstract] [Full Text] [Related]

  • 23. Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
    Grossmann Sde M, Teixeira R, de Aguiar MC, do Carmo MA.
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):702-6. PubMed ID: 18679075
    [Abstract] [Full Text] [Related]

  • 24. Autoimmune fulminant hepatic failure in chronic hepatitis C during Peg-interferon-alpha 2b plus ribavirin treatment showing histological heterogeneity.
    Yasui S, Fujiwara K, Yokosuka O.
    Dig Liver Dis; 2011 Aug; 43(8):666-7. PubMed ID: 21435960
    [No Abstract] [Full Text] [Related]

  • 25. Chronic hepatitis C genotype 6 responds better to pegylated interferon and ribavirin combination therapy than genotype 1.
    Tsang OT, Zee JS, Chan JM, Li RS, Kan YM, Li FT, Lo FH, Chow DA, Cheung KW, Chan KH, Yeung YW, Ng FH, Li MK, Kwan WK, Lai TS.
    J Gastroenterol Hepatol; 2010 Apr; 25(4):766-71. PubMed ID: 20492332
    [Abstract] [Full Text] [Related]

  • 26. [Adverse reactions of different treatments in chronic hepatitis C].
    Luca C, Grigore L, Vâţă A, Dorobăţ C.
    Rev Med Chir Soc Med Nat Iasi; 2009 Apr; 113(4):991-5. PubMed ID: 20191864
    [Abstract] [Full Text] [Related]

  • 27. Comparison of biochemical safety between PEG-IFN alpha-2a and PEG-IFN alpha-2b.
    Katano Y, Kumada T, Nakano I, Toyoda H, Ishigami M, Hayashi K, Honda T, Goto H.
    Hepatogastroenterology; 2009 Apr; 56(90):485-91. PubMed ID: 19579626
    [Abstract] [Full Text] [Related]

  • 28. Peginterferon and ribavirin for chronic hepatitis C.
    Hoofnagle JH, Seeff LB.
    N Engl J Med; 2006 Dec 07; 355(23):2444-51. PubMed ID: 17151366
    [No Abstract] [Full Text] [Related]

  • 29. Not so sweet: autoimmune diabetes mellitus on triple therapy for chronic hepatitis C infection.
    Blanchard E, Vickers CR, Samaras K.
    Diabet Med; 2015 Feb 07; 32(2):e1-3. PubMed ID: 25204264
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C.
    Yurci A, Guven K, Torun E, Gursoy S, Baskol M, Akgun H, Ozbakir O, Yucesoy M.
    Eur J Gastroenterol Hepatol; 2007 Sep 07; 19(9):811-5. PubMed ID: 17700270
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C].
    Burgueño-Montañés C, Pérez-Álvarez R.
    Arch Soc Esp Oftalmol; 2011 Jun 07; 86(6):193-5. PubMed ID: 21767697
    [Abstract] [Full Text] [Related]

  • 36. [Combination therapy for chronic viral hepatitis C].
    Zeuzem S.
    Dtsch Med Wochenschr; 2003 Feb 21; 128(8):370-4. PubMed ID: 12594622
    [No Abstract] [Full Text] [Related]

  • 37. [A case of Bell's palsy associated with peginterferon Alfa-2a and ribavirin therapy for chronic hepatitis C virus infection].
    Lee MY, Cho H, Kim YM, Lee JS.
    Korean J Hepatol; 2006 Sep 21; 12(3):444-8. PubMed ID: 16998297
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Thyroid dysfunction in patients with chronic hepatitis C: virus- or therapy-related?
    Vezali E, Elefsiniotis I, Mihas C, Konstantinou E, Saroglou G.
    J Gastroenterol Hepatol; 2009 Jun 21; 24(6):1024-9. PubMed ID: 19383078
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.